Smofkabiven Peripheral 140 mg

SMOFKABIVEN Peripheral 140 mg is an intravenous emulsion containing potassium chloride, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 140 mg is primarily used to provide essential nutrients, including potassium, to patients who cannot consume food orally. It is often used in clinical settings to support nutritional needs during intravenous therapy. This emulsion helps maintain electrolyte balance and supports overall health in patients requiring parenteral nutrition.

When administered intravenously, SMOFKABIVEN Peripheral 140 mg provides essential nutrients directly into the bloodstream. This can help maintain proper electrolyte levels and support metabolic functions. Patients may experience improved energy levels and overall well-being as a result of this nutritional support.

SMOFKABIVEN Peripheral 140 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains stable. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

SMOFKABIVEN Peripheral 140 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this product.